Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent - Wikidata - wikimedia - TriplyDB

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

http://www.wikidata.org/entity/Q27485298

about

Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor Entry inhibitors: New advances in HCV treatment New hepatitis C virus drug discovery strategies and model systems Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry Direct Infection and Replication of Naturally Occurring Hepatitis C Virus Genotypes 1, 2, 3 and 4 in Normal Human Hepatocyte Cultures CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies Combined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencing Hepatitis C virus replicons: dinosaurs still in business?Hepatitis C Virus entry: the early steps in the viral replication cycle Hepatoma Cell Density Promotes Claudin-1 and Scavenger Receptor BI Expression and Hepatitis C Virus Internalization Mouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell Line Novel Function of CD81 in Controlling Hepatitis C Virus Replication A novel small molecule inhibitor of hepatitis C virus entry Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.The missing pieces of the HCV entry puzzle.A new model to produce infectious hepatitis C virus without the replication requirement.Egress of HSV-1 capsid requires the interaction of VP26 and a cellular tetraspanin membrane protein Associations between serum lipids and hepatitis C antiviral treatment efficacy.Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity.Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases In-vitro antiviral activity of Solanum nigrum against Hepatitis C Virus.Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.Targeting of tetraspanin proteins--potential benefits and strategies Early steps of the hepatitis C virus life cycle.Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.Primary hepatocytes as targets for hepatitis C virus replication.The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.CD81 and hepatitis C virus (HCV) infection.Tight junctions in the testis: new perspectives.Advances and challenges in studying hepatitis C virus in its native environment.Hepatitis C virus entry and the tetraspanin CD81.

P2860

Q24336433-AA5F1CA6-C76E-43A4-B30B-E895462137A5 Q26770817-A11FFBD1-2899-4C2E-B6BD-9D5E4F926CDE Q26851159-EA58CF4C-0B78-4550-A96B-F4D105830418 Q26864485-B374E3A3-3551-4205-A03F-B4013B5959AC Q27485588-3943ECA4-3905-49A8-8275-97CB03290188 Q27486394-2984AF83-3E30-4A52-B5AD-7112C11F3020 Q27486789-23D12896-F28B-4568-AA93-188CAE9FC735 Q27487399-993783CE-E1E2-4E62-9E09-12287DCB9D02 Q27488834-2DF986A5-B0AE-4FD7-AE5F-913D4A556F7A Q27488905-ADF19B38-1E55-4F89-82AA-8FEF2131DCCF Q27489242-8876A77B-0C57-4EB6-9274-4DC8A7DD9B57 Q27490466-33B12F77-7A6D-4D38-8464-85DD70F2D7FE Q27490526-1EE1269F-4D7D-4EA2-999B-F97ABC1738DD Q27491131-B5B65EDE-F0A0-4B1B-997E-A7872170D89E Q28475468-E8A90BF4-B22C-4B7D-BF3B-4FD2F24366AF Q30364309-1B031666-C4B9-4D50-9FF6-C5C8225F62AF Q33360674-912E5AAD-BB37-4B41-8545-0C0F9F4D89C2 Q33886707-1147C133-13DD-487C-8D76-69559ECD5A5E Q34036057-2F85AE08-D7F9-47B0-85AF-AACCBE9A549A Q34124888-98502426-5ED9-4C9B-A3E3-B5859D583D0D Q34342117-AF813C2C-F099-45B7-B7FD-EA47FB9DA179 Q34351097-8C5944F2-F5F5-41D0-AE3C-0C7323FF8E69 Q34536782-E1CDFF24-D6CD-448E-8C02-30A986E9933E Q34547291-F1040538-D674-4F10-BD3C-8B519A80B00C Q34742966-B1B0A28F-28F8-44AF-A86B-272A36C2CC4F Q34832969-09C5E9FF-F514-4187-8E80-D638D99DD422 Q35047714-155D0F9D-83AE-4542-81F5-34DA621B9A35 Q35146636-F4CDE4C3-7C16-4124-8B01-C658F6BE170F Q35587088-BD3DFBB7-2C98-4978-ADFF-0B6755924661 Q35716330-51532FC3-F914-46C1-ADE8-7F69E976F0FA Q36369278-930E9064-0A83-49E1-A0C1-941EBED37B51 Q36533706-1485198B-3025-41FB-A6F2-52584313E3DC Q37032802-67B91540-DE65-4558-8CEE-1AF911F37F2B Q37086661-E5809100-565A-468F-871E-115C7972048A Q37352203-4A8DCDA4-2283-4D9C-8748-249354A1AD77 Q37609487-DAB642F1-F672-4252-AB9B-98F72141FBD7 Q37611819-723B9F5A-5838-4545-85D1-967A503ABBAA Q37733955-48FD1F36-E121-4BFD-8997-63A7797D6C2D Q37798816-7CBB4A2E-6957-4139-A43A-A28AC464D306 Q37856393-7718AFFB-DD68-42FC-9042-3566F6928CED

P2860

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

http://www.wikidata.org/entity/Q27485298

description

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

article scientifique (publié 2008-01)

@fr

articolo scientifico (pubblicato il 2008-01)

@it

artigo científico (publicado na 2008-01)

@pt

artículu científicu espublizáu en 2008

@ast

im Januar 2008 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 2008)

@en

vedecký článok (publikovaný 2008-01)

@sk

vetenskaplig artikel (publicerad på 2008-01)

@sv

name

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@ast

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@en

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@nl

type

label

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@ast

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@en

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@nl

prefLabel

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@ast

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@en

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@nl

P1433

Q27485298-9769D417-3C08-4DA9-A147-688D549CC3C1

P1476

Q27485298-9DF99513-847A-47DC-B91E-43C1C3B19917

P2093

Q27485298-0794C340-611D-49B2-9AF2-DBF3DBBD0D46

Q27485298-0D7599A4-0AA7-4043-951E-E8A01BF11096

Q27485298-251BF02A-72C9-4D4A-97DC-68B9B2AABB0D

Q27485298-505D2572-2E2A-4517-BB19-75B8D613E28D

Q27485298-617AE4D4-B233-44CF-8638-8614B8D1BCB5

Q27485298-6A7278D7-DD4B-4C24-AF7A-C061105ECC50

Q27485298-96C8DFDC-16F0-4B2E-8620-B178ACF51BA9

Q27485298-A1F962A6-B0BB-4083-A5DE-A2CB46E77F32

Q27485298-D282C672-A857-42E0-8EB7-C437E80782F4

Q27485298-DF38D1C7-E8F7-4461-971E-5D3804F8FA17

P2860

Q27485298-00D6F983-DFEF-4415-8617-FD5AC86AD603

Q27485298-023010CC-1ADA-499A-9390-8E73749126E7

Q27485298-088431C6-7261-40DA-86A5-B2BD5D26A9A9

Q27485298-0CB95CB7-62A9-4D36-8DD0-BE5578DA7893

Q27485298-14D1FC35-D218-470F-971B-E1C6AE06BDEA

Q27485298-254A06EC-DACA-45E0-8C1B-41CE2633AEFD

Q27485298-2552773E-F9B8-46A4-8DFD-CC458073FA06

Q27485298-281642B3-F6B8-4D31-8BE9-861A34429AB7

Q27485298-29F4D72D-6599-4495-97F8-B1F72F2505AD

Q27485298-2A19C48E-732E-43CA-8384-47C2576826C9

P304

Q27485298-06FD691A-3BBB-46D4-8E7F-7DFB0EDAD76A

P31

Q27485298-8471F17E-C9D9-4FC6-A9D0-BF64334576C0

P356

Q27485298-C4F5216C-E55A-498F-B7CD-570F295503D5

P433

Q27485298-E776BF93-F100-4784-9536-A27F5204AF5B

P478

Q27485298-B386BEB8-DF9A-4AC7-8A8E-604203116871

P50

Q27485298-2DE6D3FC-3D5B-4348-AAC7-424949588AF4

Q27485298-5B1D3C34-8EB2-4B47-B8A5-3FF586BDD6EB

Q27485298-5B61A390-0E15-47FB-A873-E9DB269FC179

Q27485298-7F53B833-67D2-41B3-AE3B-ECBBB464157A

P577

Q27485298-ED93C500-15D5-4754-9670-488920D4A89C

P698

Q27485298-D28B892D-A20B-45F6-8197-9354C9713252

P921

Q27485298-5b9ce059-40c9-acb0-7535-1204bf5eacf5

P932

Q27485298-A8841574-626B-4B35-A033-EA64CD61684C

P356

P1433

Journal of Virology

P1476

Serum-Derived Hepatitis C Viru ...... Is Tetraspanin CD81 Dependent

@en

P2093

Antonio Sacunha

http://www.w3.org/2001/XMLSchema#string

Camille Sureau

http://www.w3.org/2001/XMLSchema#string

Czeslaw Wychowski

http://www.w3.org/2001/XMLSchema#string

Dominique Larrey

http://www.w3.org/2001/XMLSchema#string

Eliane Meurs

http://www.w3.org/2001/XMLSchema#string

Jean-Marc Pascussi

http://www.w3.org/2001/XMLSchema#string

Jean-Michel Fabre

http://www.w3.org/2001/XMLSchema#string

Joliette Coste

http://www.w3.org/2001/XMLSchema#string

Lydiane Pichard-Garcia

http://www.w3.org/2001/XMLSchema#string

Patrick Maurel

http://www.w3.org/2001/XMLSchema#string

P2860

Binding of hepatitis C virus to CD81

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.

Structure-function analysis of hepatitis C virus envelope-CD81 binding

Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor

Robust hepatitis C virus infection in vitro.

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

P304

569-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01443-07

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P50

Jane A. McKeating

Chantal Fournier-Wirth

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17942559

http://www.w3.org/2001/XMLSchema#string

P921

Hepatitis C virus

P932

2224376

http://www.w3.org/2001/XMLSchema#string